Aton Ra Partners 10x Genomics, Inc. Transaction History

Aton Ra Partners

$50.1 Million
Q4 2023

A detailed history of Aton Ra Partners transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Aton Ra Partners holds 7,498 shares of TXG stock, worth $119,218. This represents 0.84% of its overall portfolio holdings.

Number of Shares

7,498

Previous 8,294 9.6%

Holding current value

$119,218

Previous $342,000 22.51%

% of portfolio

0.84%

Previous 0.72%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	SELL	$34.32 - $57.55 $27,318 - $45,809	-796 Reduced 9.6%	7,498 $419,000
Q3 2023 Oct 25, 2023	SELL	$40.86 - $62.98 $44,455 - $68,522	-1,088 Reduced 11.6%	8,294 $342,000
Q2 2023 Jul 18, 2023	SELL	$50.96 - $58.72 $44,233 - $50,968	-868 Reduced 8.47%	9,382 $523,000
Q1 2023 May 05, 2023	SELL	$35.33 - $55.79 $46,034 - $72,694	-1,303 Reduced 11.28%	10,250 $571,000
Q4 2022 Feb 02, 2023	SELL	$24.4 - $41.3 $76,250 - $129,062	-3,125 Reduced 21.29%	11,553 $420,000
Q3 2022 Nov 14, 2022	BUY	$28.48 - $52.59 $103,923 - $191,900	3,649 Added 33.09%	14,678 $418,000
Q2 2022 Aug 15, 2022	BUY	$36.95 - $82.41 $84,689 - $188,883	2,292 Added 26.23%	11,029 $499,000
Q1 2022 May 16, 2022	SELL	$55.7 - $145.79 $81,322 - $212,853	-1,460 Reduced 14.32%	8,737 $665,000
Q4 2021 Feb 14, 2022	SELL	$135.05 - $182.59 $578,149 - $781,667	-4,281 Reduced 29.57%	10,197 $1.52 Million
Q3 2021 Nov 15, 2021	BUY	$145.58 - $192.14 $195,805 - $258,428	1,345 Added 10.24%	14,478 $2.11 Million
Q2 2021 Aug 12, 2021	BUY	$134.22 - $202.37 $48,319 - $72,853	360 Added 2.82%	13,133 $2.57 Million
Q1 2021 May 17, 2021	BUY	$140.25 - $196.86 $1.79 Million - $2.51 Million	12,773 New	12,773 $2.31 Million

Others Institutions Holding TXG

# of Institutions

291

Shares Held

94.7M

Call Options Held

263K

Put Options Held

85.1K

View Full List

About 10x Genomics, Inc.

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.51B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

More about TXG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aton Ra Partners, based on Form 13F filings with the SEC.

News

Stay updated on Aton Ra Partners with notifications on news.

Account